The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

This study has been completed.

Sponsor:

Collaborators:

Takeda Global Research & Development Center, Inc.

LifeScan

Merck KGaA

Dupont Merck

Merck

Novo Nordisk

Information provided by:

Bethesda General Hospital, Hoogeveen

ClinicalTrials.gov Identifier:

NCT00375388

First received: September 12, 2006

Last updated: NA

Last verified: September 2006

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2002
Estimated Primary Completion Date:	No date given

Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):